Pluri Inc.
PLUR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001158780
No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Pluri Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 19 | 21 | +2 |
| Shares | 57.6K | 77.1K | +19.5K (+33.8%) |
| Value | $248.4K | $382.0K | +$133.6K (+53.8%) |
New holders (3)
Institutions that held Pluri Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 25,438 | $125.9K | 0.00% |
| Raymond James Financial Inc | 4,930 | $24.4K | 0.00% |
| Citigroup Inc | 712 | $3.52K | 0.00% |
Sold out (1)
Institutions that held Pluri Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Jane Street Group, LLC | 10,928 | $47.0K |